PTC Therapeutics (PTCT): next trial readout expected around 2027-12-31
Trials that could report in the next 12 months: 3BiopharmaCTG
Catalyst timeline
Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything PTCT is running — see methodology.
- 2027-12-31in 71wA Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
- 2029-03-15in 134wLong-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
- 2031-02-28in 236wA Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| A Study of Sepiapterin in Participants With Phenylketonuria (PKU) | Phase 3 | Recruitingstill enrolling patients | 2031-02-28 | NCT06302348 |
| Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreic… | Phase 3 | Not Yet Recruitingnot open yet | 2029-03-15 | NCT07681713 |
| A Study to Assess the Safety and Efficacy of Vatiquinone in Participan… | Phase 3 | Active Not Recruitingenrolled, still running | 2027-12-31 | NCT05515536 |
Status-change history
Every ClinicalTrials.gov change recorded for PTCT's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is PTCT's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is PTCT's lead program in?
Phase 3 — active not recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.